Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Chiome Bioscience Inc. ( (JP:4583) ) has shared an announcement.
Chiome Bioscience Inc. has issued corrections to its previously released non-consolidated financial results for the fiscal year ended December 31, 2024. The corrections pertain to minor adjustments in cash flows from operating and financing activities, as well as details in the cost of sales. These adjustments reflect slight changes in financial figures, which may have implications for stakeholders analyzing the company’s financial health and operational efficiency.
More about Chiome Bioscience Inc.
Chiome Bioscience Inc. operates in the biotechnology industry, focusing on the development of innovative therapeutic antibodies. The company is listed on the Tokyo Stock Exchange Growth market under the code 4583.
YTD Price Performance: -43.49%
Average Trading Volume: 6,009,061
Technical Sentiment Consensus Rating: Buy
Current Market Cap: Yen10.24B
Find detailed analytics on 4583 stock on TipRanks’ Stock Analysis page.